EVOGENE LTD (EVGN) Stock Income Statement
NASDAQ:EVGN - Nasdaq - IL0011050551 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 8.51M | 5.64M | 1.68M | 930.00K | 1.04M | |||
| Minority Interest Expense | 1.57M | 2.08M | 3.21M | 2.65M | 2.83M | |||
| Cost Of Goods | 6.83M | 8.04M | 6.42M | 6.48M | 570.00K | |||
| Gross Profit | 1.68M | -2.40M | -4.75M | -5.55M | 470.00K | |||
| Operating Expenses | 23.34M | 24.12M | 25.58M | 25.31M | 25.28M | |||
| Research and Development | 9.50M | 11.26M | 12.51M | 12.93M | 17.29M | |||
| Selling, General, and Administrative Expenses | 11.35M | 10.46M | 11.25M | 10.81M | 7.99M | |||
| Operating Income | -21.66M | -26.52M | -30.32M | -30.86M | -24.81M | |||
| Interest Income/Expense | 808.00K | 933.00K | -2.45M | 980.00K | -1.36M | |||
| Other Income/Expense | 2.83M | -412.00K | 3.13M | -460.00K | N/A | |||
| Non Recurring Items | -21.00K | 16.00K | -120.00K | -90.00K | N/A | |||
| Income Before Taxes | -18.05M | -25.99M | -29.75M | -30.43M | -26.17M | |||
| Income Tax | 9.00K | -33.00K | 90.00K | 10.00K | 30.00K | |||
| Net Income | -16.48M | -23.88M | -26.64M | -27.79M | -23.37M | |||
| EBITDA | -19.16M | -23.91M | -27.74M | -28.63M | -22.08M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.89 | -5.23 | -0.65 | -0.69 | -0.83 | |||
| Non GAAP EPS | -3.11 | -5.30 | -6.40 | -6.90 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 19.69% | -42.57% | -282.74% | -596.77% | 45.19% | |||
| Profit Margin | -193.69% | -423.39% | -1585.71% | -2988.17% | -2247.12% | |||
| Operating Profit Margin | -254.55% | -470.28% | -1804.76% | -3318.28% | -2385.58% | |||
All data in USD